SCHEMBL5485766

SCHEMBL5485766

N#CCCOP(N)(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10935262 0.83
SCHEMBL22652 0.83
SCHEMBL2180334 0.83 ALDH1A1 (0.33)
Water SCHEMBL6908198 0.83 LPAR3 (0.41)
SCHEMBL497349 0.83 P2RY14 (0.34)
Water SCHEMBL11512537 0.81 LPAR3 (0.40)
SCHEMBL6998234 0.81 LPAR3 (0.40)
SCHEMBL7216239 0.81 LPAR3 (0.40)
SCHEMBL6653137 0.81 LPAR3 (0.40)
SCHEMBL25422682 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025111578-A1 LINKERS COUPLING FUNCTIONAL LIGANDS TO MACROMOLECULES OLIX US, INC. (US) 2025-05-30 WO claimed
WO-2025111578-A1 LINKERS COUPLING FUNCTIONAL LIGANDS TO MACROMOLECULES OLIX US, INC. (US) 2025-05-30 WO disclosed
CN-112426538-A micro-RNAs and compositions comprising micro-RNAs 耶达研究及发展有限公司 2021-03-02 CN disclosed
CN-112055749-A Use of FUBP1 inhibitors for the treatment of hepatitis B virus infection 豪夫迈·罗氏有限公司 2020-12-08 CN disclosed
CN-107115352-B micro-RNAs and compositions comprising micro-RNAs 耶达研究及发展有限公司 2020-10-30 CN disclosed
CN-107988227-A Efficient nanoparticle form double helix widow RNA structures and preparation method thereof 株式会社百奥尼 2018-05-04 CN disclosed
CN-105765069-A Liver cancer related genes-specific siRNA, double-stranded oligo RNA molecules comprising the siRNA, and composition for preventing or treating cancer comprising the same 柏业公司 2016-07-13 CN disclosed
CN-105705639-A Dengue virus-specific sirna, double helix oligo-rna structure comprising sirna, and composition for suppressing proliferation of dengue virus comprising rna structure 柏业公司 2016-06-22 CN disclosed
CN-104114704-A High-efficiency nanoparticle-type double-helix oligo-RNA structure and preparation method thereof BIONEER CORP 2014-10-22 CN disclosed
CN-1856504-B Anti-infarction molecules VICOR TECHNOLOGIES INC 2010-12-29 CN disclosed
EP-0692535-A1 Oligonucleotides to inhibit the role of isoprenyl protein transferases SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 1996-01-17 EP disclosed
CN-1075336-A Novel biological process for the preparation of 7-ADCA MERCK & CO INC (US) 1993-08-18 CN disclosed
CN-1074484-A The new biological method of preparation 7-ACA and 7-ADAC MERCK & CO INC (US) 1993-07-21 CN disclosed
EP-0538404-A4 FIBROBLAST GROWTH FACTOR RECEPTORS 1993-05-26 EP disclosed
EP-0538404-A1 FIBROBLAST GROWTH FACTOR RECEPTORS RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1993-04-28 EP disclosed
WO-1992000999-A1 FIBROBLAST GROWTH FACTOR RECEPTORS RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1992-01-23 WO disclosed
CN-1050044-A As vaccine or be used for the treatment of the defective hepatitis virus of liver disease UNIV YALE (US) 1991-03-20 CN disclosed
CN-1040053-A S before the expression hepatitis B in methylotrophic yeast 2Albumen PHILLIPS PETROLEUM CO (US) 1990-02-28 CN disclosed
CN-1039616-A PICHIA PASTORIS ALCOHOL OXIDASE II REGULATORY REGION PHILLIPS PETROLEUM CO (US) 1990-02-14 CN disclosed
CN-1038668-A In methylotrophic yeasts, express hepatitis B S and pre-s2 protein PHILLIPS PETROLEUM CO (US) 1990-01-10 CN disclosed